NecLife
Sushil Kapoor has extensive experience in finance and accounting, with a background in chartered accountancy. Sushil has held various leadership roles in companies such as Nectar Lifesciences Limited, where Sushil is currently the Chief Financial Officer. Kapoor has also worked as a Consultant at Kapoor Sushil & Associates Chartered Accountants and as Vice President at BPSL Chandigarh. Additionally, Sushil has experience as a CFO at DCM Engineering Limited and KDDL Limited. Throughout their career, Sushil has been involved in restructuring working capital finance, heading taxation departments, and managing finance and IT departments. Sushil holds a CA, CS, LLB, and B.Com degrees from various institutions.
This person is not in any offices
NecLife
1 followers
Nectar Lifesciences (NecLife) is a pharmaceutical company. The Company is engaged in providing drugs and pharmaceuticals. It operates in the business segment of Pharmaceuticals Products. The Company's business activities include contract research and manufacturing services, active pharmaceutical ingredient (API) and intermediates, formulations, generics and over the counter (OTC), diagnostics, empty hard gelatin capsules and menthol. Its products include Cefixime Trihydrate, Cefuroxime Axetil (Amorphous), Cefpodoxime Proxetil, Cefuroxime Sodium (Sterile), Ceftazidime (Buffered), Cephalothin (Buffered), Cefazolin Sodium (Sterile), Cefprozil, Cefoperzone Sodium (Sterile), Cefpirome Sulphate (Buffered) and Cefoxitin Sodium (Sterile). It offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectible for cephalosporins. Its subsidiaries include Nectar Lifesciences UK Limited and Nectar Lifesciences US, LLC.